Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition
- 1 May 1992
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 123 (5) , 1414-1420
- https://doi.org/10.1016/0002-8703(92)91063-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Effects of the renin inhibitor A-64662 in monkeys and rats with varying baseline plasma renin activity.Hypertension, 1988
- Significance of the vascular renin-angiotensin pathway.Hypertension, 1986
- Monotherapy of essential hypertension with a converting-enzyme inhibitor.Hypertension, 1983
- Antihypertensive Therapy with MK 4211Journal of Cardiovascular Pharmacology, 1982
- Participation of the Renin System in Treatment-Resistant Hypertension as Measured by Acute Blockade of the Angiotensin Converting EnzymeAmerican Journal of Nephrology, 1982
- Use of First-Dose Response or Plasma Renin Activity to Predict the Long-Term Effect of CaptoprilJournal of Cardiovascular Pharmacology, 1980
- Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.Hypertension, 1980
- Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patientsThe American Journal of Medicine, 1976
- An Angiotensin Converting-Enzyme Inhibitor to Identify and Treat Vasoconstrictor and Volume Factors in Hypertensive PatientsNew England Journal of Medicine, 1974
- Propranolol Inhibition of Renin SecretionNew England Journal of Medicine, 1972